A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults

Yong-hua Cui,1 Yi Zheng1,2 1Department of Pediatrics, Beijing An’ding Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Beijing Institutes of Brain Disorders, Beijing, People’s Republic of China Objective: The aim of the study was...

Full description

Saved in:
Bibliographic Details
Main Authors: Cui Y, Zheng Y
Format: Article
Language:English
Published: Dove Medical Press 2016-07-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Online Access:https://www.dovepress.com/a-meta-analysis-on-the-efficacy-and-safety-of-st-john39s-wort-extract--peer-reviewed-fulltext-article-NDT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839651646092607488
author Cui Y
Zheng Y
author_facet Cui Y
Zheng Y
author_sort Cui Y
collection DOAJ
description Yong-hua Cui,1 Yi Zheng1,2 1Department of Pediatrics, Beijing An’ding Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Beijing Institutes of Brain Disorders, Beijing, People’s Republic of China Objective: The aim of the study was to investigate the efficacy and safety of St John’s wort extract and selective serotonin reuptake inhibitors (SSRIs) in the treatment of depression.Methods: Databases were searched for studies comparing efficacy and/or safety of St John’s wort extract with SSRIs in depression from 1966 to April 2015. Stata software was used for statistical analysis.Results: Twenty-seven studies met the study entry criteria. A total of 3,126 patients with depression were included. St John’s wort extract did not differ from SSRIs in clinical response, remission, and mean reduction in Hamilton Rating Scale for Depression score. St John’s wort extract had a significantly lower rate of adverse events compared to SSRIs (summary relative risk: 0.77; 95% confidence interval: 0.70, 0.84, P=0.00) and had fewer withdrawals due to adverse events. St John’s wort extract had superior safety in the management of patients with depression.Conclusion: Both St John’s wort extract and SSRIs are effective in treating mild-to-moderate depression. St John’s wort extract is safer than SSRIs. Keywords: St John’s wort, selective serotonin reuptake inhibitors, depression, meta-analysis 
format Article
id doaj-art-8a267c41f9c24a35a056304a2af3f28c
institution Matheson Library
issn 1178-2021
language English
publishDate 2016-07-01
publisher Dove Medical Press
record_format Article
series Neuropsychiatric Disease and Treatment
spelling doaj-art-8a267c41f9c24a35a056304a2af3f28c2025-06-26T01:58:36ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212016-07-01Volume 12Issue 11715172327830A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adultsCui YZheng Y0Department of PediatricsYong-hua Cui,1 Yi Zheng1,2 1Department of Pediatrics, Beijing An’ding Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Beijing Institutes of Brain Disorders, Beijing, People’s Republic of China Objective: The aim of the study was to investigate the efficacy and safety of St John’s wort extract and selective serotonin reuptake inhibitors (SSRIs) in the treatment of depression.Methods: Databases were searched for studies comparing efficacy and/or safety of St John’s wort extract with SSRIs in depression from 1966 to April 2015. Stata software was used for statistical analysis.Results: Twenty-seven studies met the study entry criteria. A total of 3,126 patients with depression were included. St John’s wort extract did not differ from SSRIs in clinical response, remission, and mean reduction in Hamilton Rating Scale for Depression score. St John’s wort extract had a significantly lower rate of adverse events compared to SSRIs (summary relative risk: 0.77; 95% confidence interval: 0.70, 0.84, P=0.00) and had fewer withdrawals due to adverse events. St John’s wort extract had superior safety in the management of patients with depression.Conclusion: Both St John’s wort extract and SSRIs are effective in treating mild-to-moderate depression. St John’s wort extract is safer than SSRIs. Keywords: St John’s wort, selective serotonin reuptake inhibitors, depression, meta-analysis https://www.dovepress.com/a-meta-analysis-on-the-efficacy-and-safety-of-st-john39s-wort-extract--peer-reviewed-fulltext-article-NDTSt. John’s wortselective serotonin reuptake inhibitorsdepressionmeta-analysis
spellingShingle Cui Y
Zheng Y
A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
Neuropsychiatric Disease and Treatment
St. John’s wort
selective serotonin reuptake inhibitors
depression
meta-analysis
title A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
title_full A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
title_fullStr A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
title_full_unstemmed A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
title_short A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
title_sort meta analysis on the efficacy and safety of st john amp 39 s wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
topic St. John’s wort
selective serotonin reuptake inhibitors
depression
meta-analysis
url https://www.dovepress.com/a-meta-analysis-on-the-efficacy-and-safety-of-st-john39s-wort-extract--peer-reviewed-fulltext-article-NDT
work_keys_str_mv AT cuiy ametaanalysisontheefficacyandsafetyofstjohnamp39swortextractindepressiontherapyincomparisonwithselectiveserotoninreuptakeinhibitorsinadults
AT zhengy ametaanalysisontheefficacyandsafetyofstjohnamp39swortextractindepressiontherapyincomparisonwithselectiveserotoninreuptakeinhibitorsinadults
AT cuiy metaanalysisontheefficacyandsafetyofstjohnamp39swortextractindepressiontherapyincomparisonwithselectiveserotoninreuptakeinhibitorsinadults
AT zhengy metaanalysisontheefficacyandsafetyofstjohnamp39swortextractindepressiontherapyincomparisonwithselectiveserotoninreuptakeinhibitorsinadults